| Dr Eric Arash Pezhman, MD | |
|
801 Broadway N, Fargo, ND 58102-3641 | |
| (701) 234-6355 | |
| Not Available |
| Full Name | Dr Eric Arash Pezhman |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 20 Years |
| Location | 801 Broadway N, Fargo, North Dakota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154531366 | NPI | - | NPPES |
| 1154531366 | Medicaid | MN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 5315022952 (Michigan) | Secondary |
| 207L00000X | Anesthesiology | 11071 (North Dakota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sanford Medical Center Fargo | Fargo, ND | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sanford Medical Center Fargo | 8426967803 | 1094 |
News Archive
Seattle Genetics, Inc. (Nasdaq: SGEN) announced today that it has achieved a milestone under its antibody-drug conjugate (ADC) collaboration with Bayer Schering Pharma AG, Germany. The milestone was triggered by Bayer's submission of an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for MN-IC, an ADC for solid tumors.
Biodel Inc. today announced that it has entered into definitive agreements with a group of institutional investors, including Great Point Partners, LLC and Orbimed Advisors, LLC, to sell approximately 12.2 million shares of its common stock, 1.7 million shares of its Series A Convertible Preferred Stock and warrants to purchase 9.0 million shares of its common stock.
The National Parkinson Foundation (NPF) is proud to announce support for three new research projects which fulfill NPF's mission of improving the quality of care in Parkinson's disease.
Glioma is the most common type of primary malignant brain tumor in the United States; glioblastoma being the most common type of glioma in adults.
In a large clinical trial testing dietary supplements for prostate cancer (PCa) prevention, baseline selenium (Se) status (measured by toenail Se concentration), in the absence of supplementation, was not associated with prostate cancer (PCa) risk.
› Verified 7 days ago
| Entity Name | Sanford Clinic North |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942241351 PECOS PAC ID: 4284546151 Enrollment ID: O20031112000221 |
News Archive
Seattle Genetics, Inc. (Nasdaq: SGEN) announced today that it has achieved a milestone under its antibody-drug conjugate (ADC) collaboration with Bayer Schering Pharma AG, Germany. The milestone was triggered by Bayer's submission of an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for MN-IC, an ADC for solid tumors.
Biodel Inc. today announced that it has entered into definitive agreements with a group of institutional investors, including Great Point Partners, LLC and Orbimed Advisors, LLC, to sell approximately 12.2 million shares of its common stock, 1.7 million shares of its Series A Convertible Preferred Stock and warrants to purchase 9.0 million shares of its common stock.
The National Parkinson Foundation (NPF) is proud to announce support for three new research projects which fulfill NPF's mission of improving the quality of care in Parkinson's disease.
Glioma is the most common type of primary malignant brain tumor in the United States; glioblastoma being the most common type of glioma in adults.
In a large clinical trial testing dietary supplements for prostate cancer (PCa) prevention, baseline selenium (Se) status (measured by toenail Se concentration), in the absence of supplementation, was not associated with prostate cancer (PCa) risk.
› Verified 7 days ago
| Entity Name | Sanford Medical Center Fargo |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184917924 PECOS PAC ID: 8426967803 Enrollment ID: O20110331000495 |
News Archive
Seattle Genetics, Inc. (Nasdaq: SGEN) announced today that it has achieved a milestone under its antibody-drug conjugate (ADC) collaboration with Bayer Schering Pharma AG, Germany. The milestone was triggered by Bayer's submission of an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for MN-IC, an ADC for solid tumors.
Biodel Inc. today announced that it has entered into definitive agreements with a group of institutional investors, including Great Point Partners, LLC and Orbimed Advisors, LLC, to sell approximately 12.2 million shares of its common stock, 1.7 million shares of its Series A Convertible Preferred Stock and warrants to purchase 9.0 million shares of its common stock.
The National Parkinson Foundation (NPF) is proud to announce support for three new research projects which fulfill NPF's mission of improving the quality of care in Parkinson's disease.
Glioma is the most common type of primary malignant brain tumor in the United States; glioblastoma being the most common type of glioma in adults.
In a large clinical trial testing dietary supplements for prostate cancer (PCa) prevention, baseline selenium (Se) status (measured by toenail Se concentration), in the absence of supplementation, was not associated with prostate cancer (PCa) risk.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Eric Arash Pezhman, MD 801 Broadway N, Fargo, ND 58102-3641 Ph: (701) 234-6355 | Dr Eric Arash Pezhman, MD 801 Broadway N, Fargo, ND 58102-3641 Ph: (701) 234-6355 |
News Archive
Seattle Genetics, Inc. (Nasdaq: SGEN) announced today that it has achieved a milestone under its antibody-drug conjugate (ADC) collaboration with Bayer Schering Pharma AG, Germany. The milestone was triggered by Bayer's submission of an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for MN-IC, an ADC for solid tumors.
Biodel Inc. today announced that it has entered into definitive agreements with a group of institutional investors, including Great Point Partners, LLC and Orbimed Advisors, LLC, to sell approximately 12.2 million shares of its common stock, 1.7 million shares of its Series A Convertible Preferred Stock and warrants to purchase 9.0 million shares of its common stock.
The National Parkinson Foundation (NPF) is proud to announce support for three new research projects which fulfill NPF's mission of improving the quality of care in Parkinson's disease.
Glioma is the most common type of primary malignant brain tumor in the United States; glioblastoma being the most common type of glioma in adults.
In a large clinical trial testing dietary supplements for prostate cancer (PCa) prevention, baseline selenium (Se) status (measured by toenail Se concentration), in the absence of supplementation, was not associated with prostate cancer (PCa) risk.
› Verified 7 days ago
Dr. Latif Sean Ougzin, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 3000 32nd Ave S, Fargo, ND 58103 Phone: 701-364-8000 Fax: 701-364-8078 | |
Manuel A. Colon-dejesus, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 801 Broadway N, Fargo, ND 58102 Phone: 701-234-5621 | |
John V Vinych, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3000 32nd Ave S, Fargo, ND 58103 Phone: 701-364-8000 Fax: 701-364-8078 | |
Patrick J. Indergaard, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 801 Broadway N, Fargo, ND 58102 Phone: 701-234-6258 Fax: 701-234-7334 | |
Shelby Suzanne Best, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3000 32nd Ave S, Fargo, ND 58103 Phone: 701-364-8000 | |
Layne Egan, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 5225 23rd Ave S, Fargo, ND 58104 Phone: 701-417-2575 | |
Alanna Velo, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 801 Broadway N, Fargo, ND 58102 Phone: 218-205-7365 |